Millendo Therapeutics Announces Positive Topline Phase 2 Results of ATR-101 in Classic Congenital Ad
ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
Oct 19, 2017
Gritstone Oncology and Arbutus Biopharma Announce LNP Technology Licensing Agreement to Develop Nove
VANCOUVER, British Columbia and WARMINSTER, Pa. and EMERYVILLE, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation...
Oct 18, 2017
Vir Biotechnology Builds Pipeline, Capabilities, and Lays Out Strategy to Address Serious Infectious
-- Expands technology and global footprint with acquisition of Humabs BioMed SA -- Accesses clinical and preclinical stage assets from...
Oct 4, 2017
eFFECTOR Therapeutics Initiates Dosing in Phase 2 Combination Trial of EFT508 and Avelumab in Micros
Study conducted in collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer SAN DIEGO, October 4, 2017 – eFFECTOR Therapeutics,...
Sep 26, 2017
Vir Biotechnology: Fierce15 Winner
This quiet biotech is looking for curative therapies and new vaccines for a host of infectious diseases with an experienced biopharma...
Sep 26, 2017
FierceBiotech Names Gritstone Oncology as a "Fierce 15" Biotechnology Company of 2017
Emeryville, CA, September 26, 2017 – Gritstone Oncology, a next-generation personalized cancer immunotherapy company, has been named by...
Sep 26, 2017
BlackThorn Selected as a Fierce15 2017 Winner
BlackThorn Therapeutics has been selected as one of the “Fierce 15” winners for 2017. With this designation, BlackThorn is considered one...
Sep 26, 2017
AgTech Startup Indigo Is Boston’s Newest Unicorn After $156M Series D
Boston-based Indigo announced Tuesday the first closing of $156 million in its Series D financing, doubling the company’s total capital...
Sep 7, 2017
Gritstone Oncology Secures $92.7 Million In Series B Financing
Proceeds Will Support Further Development of Proprietary Tumor Antigen Identification Platform and Advancement of Pipeline of...
bottom of page